Aernoud Fiolet

153 Colchicine in Patients with Chronic Coronary Disease Table S5 On-Treatment Analysis for the Primary End Point Colchicine (N = 2740) Placebo (N = 2738) Hazard Ratio (95% CI) no. (%) rate /100 person -yr no. (%) rate /100 person -yr Cardiovascular death, myocardial infarction*, ischemic stroke or ischemia-driven coronary revascularization 162 (5.9) 2.3 245 (8.9) 3.6 0.64 (0.53-0.78) * Myocardial infarction refers to spontaneous (nonprocedural) myocardial infarction